| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 8744516 | Anaerobe | 2018 | 4 Pages | 
Abstract
												The in vitro activities of lascufloxacin were evaluated by comparison with seven reference compounds using 412 clinical isolates of anaerobes and Streptococcus anginosus group. Lascufloxacin showed potent and broad antibacterial activities greater than those of existing quinolones against the clinical isolates used in this study.
											Keywords
												
											Related Topics
												
													Life Sciences
													Immunology and Microbiology
													Microbiology
												
											Authors
												Yuka Yamagishi, Yoko Matsukawa, Hiroyuki Suematsu, Hiroshige Mikamo, 
											